These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7798126)
61. The new antiepileptic drugs. Appleton RE Arch Dis Child; 1996 Sep; 75(3):256-62. PubMed ID: 8976672 [No Abstract] [Full Text] [Related]
62. Improvement of stiff-man syndrome with vigabatrin. Sharoqi IA Neurology; 1998 Mar; 50(3):833-4. PubMed ID: 9521301 [No Abstract] [Full Text] [Related]
63. Gamma-vinyl GABA (vigabatrin) and mood disturbances. Aldenkamp AP; Vermeulen J; Mulder OG; Overweg J; Van Parys JA; Beun AM; Van 't Slot B Epilepsia; 1994; 35(5):999-1004. PubMed ID: 7925172 [TBL] [Abstract][Full Text] [Related]
64. New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin. Devinsky O; Vazquez B; Luciano D J Child Neurol; 1994 Oct; 9 Suppl 1():S33-45. PubMed ID: 7822751 [TBL] [Abstract][Full Text] [Related]
65. Transient motor aphasia and recurrent partial seizures in a child: language recovery upon seizure control. Jambaqué I; Chiron C; Kaminska A; Plouin P; Dulac O J Child Neurol; 1998 Jun; 13(6):296-300. PubMed ID: 9660518 [No Abstract] [Full Text] [Related]
66. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study. Feucht M; Brantner-Inthaler S Epilepsia; 1994; 35(5):993-8. PubMed ID: 7925171 [TBL] [Abstract][Full Text] [Related]
67. Improvement of stiff-man syndrome with vigabatrin. Vermeij FH; van Doorn PA; Busch HF Lancet; 1996 Aug; 348(9027):612. PubMed ID: 8774586 [No Abstract] [Full Text] [Related]
68. Examining the role of vigabatrin. Mackenzie RA Neurology; 1996 Jul; 47(1 Suppl 1):S1. PubMed ID: 8677030 [No Abstract] [Full Text] [Related]
69. [Vigabatrin in the treatment of infantile spasms]. Backström M; Eriksson K; Koivikko M Duodecim; 1995; 111(9):853-5. PubMed ID: 8681848 [No Abstract] [Full Text] [Related]
70. [Vigabatrin symposium within the congress "Epilepsy Europe", 3 September 1992, Glasgow]. Nervenarzt; 1992 Dec; 63(12 Suppl):1-12. PubMed ID: 7477593 [No Abstract] [Full Text] [Related]
71. [Vigabatrin in the treatment of pediatric epileptic syndrome]. Lahat E Harefuah; 1995 Mar; 128(5):306-8. PubMed ID: 7744355 [No Abstract] [Full Text] [Related]
73. Reversible global aphasia as a side effect of quetiapine: a case report and literature review. Chien CF; Huang P; Hsieh SW Neuropsychiatr Dis Treat; 2017; 13():2257-2260. PubMed ID: 28894370 [TBL] [Abstract][Full Text] [Related]
74. Biological approaches to aphasia treatment. Small SL; Llano DA Curr Neurol Neurosci Rep; 2009 Nov; 9(6):443-50. PubMed ID: 19818231 [TBL] [Abstract][Full Text] [Related]
75. Adverse reactions to new anticonvulsant drugs. Wong IC; Lhatoo SD Drug Saf; 2000 Jul; 23(1):35-56. PubMed ID: 10915031 [TBL] [Abstract][Full Text] [Related]
76. Rapid aggravation of aphasia by vigabatrin. Gil R; Neau JP J Neurol; 1995 Mar; 242(4):251-2. PubMed ID: 7798126 [No Abstract] [Full Text] [Related]
78. Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin. Mackenzie R; Klistorner A BMJ; 1998 Jan; 316(7126):233. PubMed ID: 9468717 [No Abstract] [Full Text] [Related]
79. Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing. Blackwell N; Hayllar J; Kelly G BMJ; 1997 Jun; 314(7095):1694. PubMed ID: 9193313 [No Abstract] [Full Text] [Related]